Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biosym A/S
A/S
Active
Advertising protection
CVR 21774189
Lene Haus Vej 25, 7430
Ikast
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1999 · 27 years old
19 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Biosym A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
30M
22M
15M
7M
0M
2021: 19M
19M
2021
2022: 13M (-32% vs 2021)
13M
-32%
2022
2023: 15M (+15% vs 2022)
15M
+15%
2023
2024: 16M (+7% vs 2023)
16M
+7%
2024
2025: 24M (+50% vs 2024)
24M
+50%
2025
EBITDA
DKK millions
15M
11M
7M
4M
0M
2021: 10M
10M
2021
2022: 4M (-60% vs 2021)
4M
-60%
2022
2023: 6M (+50% vs 2022)
6M
+50%
2023
2024: 6M (0% vs 2023)
6M
0%
2024
2025: 12M (+100% vs 2024)
12M
+100%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
23.553
16.196
15.335
12.991
18.635
Staff expenses
-11.658
-10.322
-9.274
-8.789
-8.237
EBITDA
11.894
5.874
6.062
4.202
10.376
Depreciation & amort.
-464
-428
-573
-794
-847
EBIT
11.430
5.446
5.489
3.408
9.530
Net financials
-492
-553
-914
-735
-417
Profit before tax
10.938
4.893
4.575
2.673
9.113
Tax
2.408
1.082
463
563
2.005
Net profit
8.530
3.811
4.112
2.110
7.108
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
72.550
58.197
57.826
71.573
55.319
Equity
46.312
37.781
33.970
29.859
27.749
Long-term debt
4.798
8.917
12.941
16.336
9.176
Short-term debt
21.440
11.500
10.915
25.378
18.394
Total debt
26.238
20.416
23.855
41.714
27.570
Financial ratios
5-year trend
EBITDA margin (of gross profit)
50,5 %
This company
2021
2025
Equity ratio
63,8 %
This company
38,2 %
Market median
This company
Market median
67% above market
2021
2025
Return on equity
18,4 %
This company
18,4 %
Market median
This company
Market median
0% above market
2021
2025
Net profit margin (of gross profit)
36,2 %
This company
2021
2025
Asset turnover (of gross profit)
0,32×
This company
2021
2025
Debt / equity
0,57×
This company
0,62×
Market median
This company
Market median
8% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biosym A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
